DuPont’s New Manufacturing Facility in Singapore

January 2021

DuPont Nutrition & Biosciences has announced the mechanical completion of its new Flexiblend facility in Singapore. The new plant will leverage DuPont’s advanced biotechnology and global quality standards to provide customized solutions to industry partners in Asia Pacific and will begin operations in second quarter of 2021.
Biotechnology solutions produced in the plant will include flexible blending of enzymes, customized for Asia. Enzymes are highly specialized proteins that improve the sustainability of conventional processes by reducing the use of chemicals, enabling energy efficiency, water efficiency, and waste reduction. Enzymes are used in a wide range of applications such as animal nutrition, grain processing, home care, food & beverage and many others.
DuPont’s new facility is an example of how biotechnology companies can leverage Singapore as a hub to innovate, manufacture and deliver sustainable products and solutions to consumers and industries in the region.
(Source: DuPont)

Our Services

Orissa International provides consulting services to companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 distributors, resellers, and system integrators, built through advising and guiding more than 5,000 companies with their market expansion into Singapore, Malaysia, Indonesia, Thailand, Vietnam and the Philippines over the last 25 years.